Early prediction of lung scarring after COVID using explainable AI
Predicting Post-Covid Pulmonary Fibrosis with Explainable Deep Learning and Optimal Biomarker Discovery
This project uses explainable AI on CT scans and medical records to find people at risk of lung scarring after COVID-19.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11178702 on NIH RePORTER |
What this research studies
If I join, researchers will combine my chest CT images and electronic health-record data and apply explainable deep learning to spot early signs of post-COVID lung fibrosis. They will use patient data pooled from multiple hospitals, including Northwestern and Columbia, to train and validate the models. The team will search for imaging and clinical biomarkers and show which features the AI models rely on. The goal is a transparent tool that can identify at-risk patients earlier so doctors can consider timely treatments.
Who could benefit from this research
Good fit: Ideal candidates are people who had COVID-19—especially those hospitalized or with persistent breathing problems—who have recent chest CT scans and accessible medical records.
Not a fit: People without prior COVID-19, without chest imaging or medical records, or whose lung disease is from a different cause may not benefit from this project.
Why it matters
Potential benefit: If successful, this work could help doctors identify people at high risk for post-COVID lung fibrosis earlier so treatments might be started sooner to limit scarring.
How similar studies have performed: Previous studies have used machine learning to find fibrosis patterns on CT, but combining explainable deep learning with multimodal EHR across multiple centers is relatively new.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Bagci, Ulas — Northwestern University
- Study coordinator: Bagci, Ulas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.